Study to Investigate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Single & Repeat Doses of GSK2269557

NCT01462617 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: GSK2269557
DRUG: GSK2269557 matching placebo

Sponsor

GlaxoSmithKline